Biovica International AB (publ) - Asset Resilience Ratio

Latest as of July 2025: 28.69%

Biovica International AB (publ) (BIOVIC-B) has an Asset Resilience Ratio of 28.69% as of July 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

Skr16.30 Million

≈ $1.75 Million USD Cash + Short-term Investments

Total Assets

Skr56.82 Million

≈ $6.11 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio Trend (2016–2025)

This chart shows how Biovica International AB (publ)'s Asset Resilience Ratio has changed over time. Check BIOVIC-B strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Biovica International AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Biovica International AB (publ) (BIOVIC-B) market capitalisation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr16.30 Million	28.69%
Short-term Investments	Skr0.00	0%
Total Liquid Assets	Skr16.30 Million	28.69%

Asset Resilience Insights

Very High Liquidity: Biovica International AB (publ) maintains exceptional liquid asset reserves at 28.69% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Biovica International AB (publ) Industry Peers by Asset Resilience Ratio

Compare Biovica International AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Tubize-Fin BR:TUB	Biotechnology	0.05%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Xiamen Amoytop Biotech Co Ltd SHG:688278	Biotechnology	4.69%
Syndax Pharmaceuticals Inc NASDAQ:SNDX	Biotechnology	46.79%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Vor Biopharma Inc NASDAQ:VOR	Biotechnology	63.47%
Chengdu Kanghua Biological Products SHE:300841	Biotechnology	1.19%
Jiangsu Aidea Pharmaceutical Co Ltd SHG:688488	Biotechnology	4.35%

Annual Asset Resilience Ratio for Biovica International AB (publ) (2016–2025)

The table below shows the annual Asset Resilience Ratio data for Biovica International AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-04-30	0.00%	Skr0.00 ≈ $0.00	Skr64.95 Million ≈ $6.99 Million	--
2024-04-30	19.55%	Skr25.68 Million ≈ $2.76 Million	Skr131.41 Million ≈ $14.14 Million	+5.38pp
2023-04-30	14.17%	Skr24.41 Million ≈ $2.63 Million	Skr172.29 Million ≈ $18.54 Million	-53.21pp
2022-04-30	67.38%	Skr102.17 Million ≈ $11.00 Million	Skr151.63 Million ≈ $16.32 Million	-8.08pp
2021-04-30	75.46%	Skr145.38 Million ≈ $15.64 Million	Skr192.65 Million ≈ $20.73 Million	+30.27pp
2020-04-30	45.19%	Skr40.79 Million ≈ $4.39 Million	Skr90.26 Million ≈ $9.71 Million	-2.07pp
2019-04-30	47.26%	Skr28.76 Million ≈ $3.10 Million	Skr60.86 Million ≈ $6.55 Million	-4.89pp
2018-04-30	52.16%	Skr42.13 Million ≈ $4.53 Million	Skr80.77 Million ≈ $8.69 Million	-15.21pp
2017-04-30	67.37%	Skr65.47 Million ≈ $7.05 Million	Skr97.18 Million ≈ $10.46 Million	+67.43pp
2016-04-30	-0.07%	Skr-19.81K ≈ $-2.13K	Skr28.73 Million ≈ $3.09 Million	--

pp = percentage points

About Biovica International AB (publ)

ST:BIOVIC-B Sweden Biotechnology

Market Cap

$14.81 Million

Skr137.64 Million SEK

Market Cap Rank

#25994 Global

#542 in Sweden

Share Price

Skr0.50

Change (1 day)

+0.00%

52-Week Range

Skr0.28 - Skr0.69

All Time High

Skr66.10